Drugs / [123]I-CNS 1261
last change Jul 2005 re-read 2 minutes ago

[123]I-CNS 1261

Investigated by
GlaxoSmithKline

Trials 1 · a red edge is where a trial was stopped

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00364429 Jul 2005 schizophrenia GlaxoSmithKline Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as [123]I-CNS 1261 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00364429